{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:54:59Z","timestamp":1775800499263,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1871"],"award-info":[{"award-number":["2024NSFSC1871"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473776"],"award-info":[{"award-number":["82473776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024YFHZ0185"],"award-info":[{"award-number":["2024YFHZ0185"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117459","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:55:09Z","timestamp":1761353709000},"page":"117459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Non-covalent mTOR inhibition suppresses NLRP3-GSDMD inflammasome-mediated pyroptosis"],"prefix":"10.1016","volume":"243","author":[{"given":"Xueqin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruijia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyue","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenshuang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcp.2025.117459_b0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2025.117459_b0010","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/jcp.29268","article-title":"Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases","volume":"235","author":"Lu","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2025.117459_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101805","article-title":"Pyroptosis in defense against intracellular bacteria","volume":"69","author":"Li","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bcp.2025.117459_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.711939","article-title":"The role and mechanism of pyroptosis and potential therapeutic targets in sepsis: a review","volume":"12","author":"Zheng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117459_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1338125","article-title":"Unveiling the flames: macrophage pyroptosis and its crucial role in liver diseases","volume":"15","author":"Ni","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117459_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2022.100166","article-title":"A novel mechanism for NLRP3 inflammasome activation","volume":"13","author":"Zhang","year":"2022","journal-title":"Metabol Open"},{"issue":"8","key":"10.1016\/j.bcp.2025.117459_b0035","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4049\/immunohorizons.2200058","article-title":"NLRP3 inflammasome priming and activation are regulated by a phosphatidylinositol-dependent mechanism","volume":"6","author":"Hamilton","year":"2022","journal-title":"Immunohorizons"},{"issue":"2","key":"10.1016\/j.bcp.2025.117459_b0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-\u03baB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117459_b0045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117459_b0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"7610","key":"10.1016\/j.bcp.2025.117459_b0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2025.117459_b0060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/08830185.2024.2415688","article-title":"The NLRP3 inflammasome: Mechanisms of activation, regulation, and role in diseases","volume":"44","author":"Dadkhah","year":"2025","journal-title":"Int. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117459_b0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11481-024-10101-5","article-title":"New insights on NLRP3 inflammasome: Mechanisms of activation, Inhibition, and epigenetic regulation","volume":"19","author":"Kodi","year":"2024","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117459_b0070","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri3901","article-title":"Regulation of innate immune cell function by mTOR","volume":"15","author":"Weichhart","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117459_b0075","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2025.117459_b0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117459_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-430-8_1","article-title":"Mammalian target of rapamycin: a signaling kinase for every aspect of cellular life","volume":"821","author":"Weichhart","year":"2012","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117459_b0090","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1038\/s41467-024-48386-y","article-title":"mTORC1 regulates cell survival under glucose starvation through 4EBP1\/2-mediated translational reprogramming of fatty acid metabolism","volume":"15","author":"Levy","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117459_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110892","article-title":"Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks","volume":"441","author":"Magnuson","year":"2012","journal-title":"Biochem. J"},{"issue":"11","key":"10.1016\/j.bcp.2025.117459_b0100","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.cell.2022.04.013","article-title":"mTOR substrate phosphorylation in growth control","volume":"185","author":"Battaglioni","year":"2022","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bcp.2025.117459_b0105","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008771","article-title":"mTOR-dependent cell survival mechanisms","volume":"4","author":"Hung","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bcp.2025.117459_b0110","doi-asserted-by":"crossref","unstructured":"C.L. Evavold, I. Hafner-Bratkovic, P. Devant, J.M. D'Andrea, E.M. Ngwa, E. Borsic, J.G. Doench, M.W. LaFleur, A.H. Sharpe, J.R. Thiagarajah, J.C. Kagan, Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway, Cell 184(17) (2021) 4495-4511 e19.","DOI":"10.1016\/j.cell.2021.06.028"},{"issue":"10","key":"10.1016\/j.bcp.2025.117459_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102405","article-title":"Endosomal mTORC2 is required for phosphoinositide-dependent AKT activation in platelet-derived growth factor-stimulated glioma cells","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2025.117459_b0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fonc.2013.00165","article-title":"The paradox of akt-mTOR interactions","volume":"3","author":"Vadlakonda","year":"2013","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117459_b0125","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4049\/jimmunol.2100230","article-title":"mTORC1 signaling regulates proinflammatory macrophage function and metabolism","volume":"207","author":"Collins","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2025.117459_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102373","article-title":"The immunobiology of mTOR in autoimmunity","volume":"110","author":"Suto","year":"2020","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.bcp.2025.117459_b0135","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1002\/jcp.26276","article-title":"Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives","volume":"233","author":"Soltani","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117459_b0140","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12964-024-01699-3","article-title":"Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy","volume":"22","author":"Wang","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.bcp.2025.117459_b0145","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2025.117459_b0150","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/abbs\/gmy088","article-title":"mTOR regulates NLRP3 inflammasome activation via reactive oxygen species in murine lupus","volume":"50","author":"Li","year":"2018","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"5","key":"10.1016\/j.bcp.2025.117459_b0155","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/bcp.12893","article-title":"New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation","volume":"82","author":"Waldner","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117459_b0160","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025924","article-title":"Inhibition of the mechanistic target of rapamycin (mTOR)-rapamycin and beyond","volume":"6","author":"Lamming","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"9","key":"10.1016\/j.bcp.2025.117459_b0165","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1074\/jbc.AAC120.012837","article-title":"An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1","volume":"295","author":"Thoreen","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117459_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102886","article-title":"Mechanisms of resistance to mTOR inhibitors","volume":"147","author":"Formisano","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117459_b0175","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/jm101520v","article-title":"Discovery of 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a potent, selective, and orally available mammalian target of rapamycin (mTOR) inhibitor for treatment of cancer","volume":"54","author":"Liu","year":"2011","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2025.117459_b0180","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.1000038","article-title":"Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2","volume":"7","author":"Feldman","year":"2009","journal-title":"PLoS Biol."},{"issue":"9","key":"10.1016\/j.bcp.2025.117459_b0185","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.chembiol.2015.07.018","article-title":"Identification and characterization of an irreversible inhibitor of CDK2","volume":"22","author":"Anscombe","year":"2015","journal-title":"Chem. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117459_b0190","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi9284","article-title":"NU6300 covalently reacts with cysteine-191 of gasdermin D to block its cleavage and palmitoylation","volume":"10","author":"Jiang","year":"2024","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.bcp.2025.117459_b0195","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/intimm\/dxx018","article-title":"Mechanisms governing inflammasome activation, assembly and pyroptosis induction","volume":"29","author":"Kesavardhana","year":"2017","journal-title":"Int. Immunol."},{"issue":"7329","key":"10.1016\/j.bcp.2025.117459_b0200","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2025.117459_b0205","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nri2725","article-title":"NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?","volume":"10","author":"Tschopp","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117459_b0210","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"issue":"7717","key":"10.1016\/j.bcp.2025.117459_b0215","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","article-title":"New mitochondrial DNA synthesis enables NLRP3 inflammasome activation","volume":"560","author":"Zhong","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2025.117459_b0220","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"issue":"5022","key":"10.1016\/j.bcp.2025.117459_b0225","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1126\/science.1715094","article-title":"Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast","volume":"253","author":"Heitman","year":"1991","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bcp.2025.117459_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043418","article-title":"Inhibitory effect of mTOR activator MHY1485 on autophagy: suppression of lysosomal fusion","volume":"7","author":"Choi","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bcp.2025.117459_b0235","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"7448","key":"10.1016\/j.bcp.2025.117459_b0240","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12122","article-title":"mTOR kinase structure, mechanism and regulation","volume":"497","author":"Yang","year":"2013","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bcp.2025.117459_b0245","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/CS20230522","article-title":"Inflammatory liver diseases and susceptibility to sepsis","volume":"138","author":"Lu","year":"2024","journal-title":"Clin. Sci. (Lond.)"},{"issue":"2","key":"10.1016\/j.bcp.2025.117459_b0250","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbrc.2017.11.159","article-title":"Isoliquiritigenin protects against sepsis-induced lung and liver injury by reducing inflammatory responses","volume":"496","author":"Chen","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2025.117459_b0255","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.it.2009.02.002","article-title":"The multiple facets of mTOR in immunity","volume":"30","author":"Weichhart","year":"2009","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117459_b0260","first-page":"131","article-title":"Acetaminophen-induced hepatotoxicity: a comprehensive update","volume":"4","author":"Yoon","year":"2016","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117459_b0265","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.slast.2023.08.004","article-title":"High-throughput differential scanning fluorimetry (DSF) and cellular thermal shift assays (CETSA): Shifting from manual to automated screening","volume":"28","author":"Hansel","year":"2023","journal-title":"SLAS Technol."},{"issue":"51","key":"10.1016\/j.bcp.2025.117459_b0270","doi-asserted-by":"crossref","first-page":"21984","DOI":"10.1073\/pnas.0910040106","article-title":"Target identification using drug affinity responsive target stability (DARTS)","volume":"106","author":"Lomenick","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bcp.2025.117459_b0275","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jbmr.2031","article-title":"mTORC2 regulates mechanically induced cytoskeletal reorganization and lineage selection in marrow-derived mesenchymal stem cells","volume":"29","author":"Sen","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bcp.2025.117459_b0280","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jmr.928","article-title":"Survey of the year 2007 commercial optical biosensor literature","volume":"21","author":"Rich","year":"2008","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.bcp.2025.117459_b0285","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2147\/OTT.S84200","article-title":"Determination and validation of mTOR kinase-domain 3D structure by homology modeling","volume":"8","author":"Lakhlili","year":"2015","journal-title":"Oncol. Targets Ther."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225007245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:01:33Z","timestamp":1775797293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225007245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":57,"alternative-id":["S0006295225007245"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117459","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-covalent mTOR inhibition suppresses NLRP3-GSDMD inflammasome-mediated pyroptosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117459"}}